Randomization of Oxytocin, Oxytocin+Intrauterine Misoprostol and Carbetosin During C-section
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
Postpartum haemorrhage (PPH) remains an important cause of maternal morbidity and mortality
and it accounts for approximately 25% of all deaths worldwide. Drugs such as oxytocin,
carbetocin, misoprostol, prostaglandin F2a and methylergonovine have been tested for bleeding
control during and after cesarean section. Oxytocin is the most widely used agent for the
prevention of postpartum hemorrhage.The primary aim of this study is to reduce the mean blood
loss during cesarean section.In this study, we planned to compare perop and postoperative
blood loss levels by giving oxytocin alone to the 1st group, oxytocin and intrauterine
misoprostol to the 2nd group, and carbetocin to the 3rd group of patients who were randomly
divided into 3 groups.In this study, we aimed to compare the efficacy of oxytocin,
misoprostol and carbetocin in preventing uterine blood loss during cesarean section.